INITIATIVES

10/02/2012

Nice: Creation of the Institute of Research on Cancer and Ageing, IRCAN

IRCAN was created on 1st January 2012 and is located at the Pasteur University Hospital Centre in Nice. It is run by Prof. Eric Gilson


IRCAN is greatly involved in research activities but also education and training.

 

The Centre Director is assisted by an international scientific committee. The Centre is affiliated to the University of Nice Sophia Antipolis, the CNRS, INSERM and the Centre Antoine Lacassagne and works closely with the Nice University Hospital Centre.

 

The objective

For today's fortunate population who can expect to live increasingly longer lives, the major challenge is staying healthy and independent in order to tackle this stage of life in the best conditions. Indeed, age remains the primary risk factor in cancer and degenerative diseases affecting the nervous, renal, cardio-vascular and metabolic systems.

IRCAN's research work aims to understand more about the ageing process and cancer. The results obtained will provide a better understanding of the dysfunctions arising from cancers, certain forms of diabetes, kidney failure, neuro-degenerative and cardio-vascular diseases.

 

These studies will result in new diagnosis tests and the development of therapeutic strategies to treat various types of cancers and counteract the organ degeneration related to ageing and environmental stress.


En savoir plus : ircan.org/

Contact

They chose the Côte d'Azur

"Sophia-Antipolis is a very attractive region for any semiconductor company, for several reasons. The first one is that in the technology park of Sophia-Antipolis there is a solid tradition of analog and digital design, which is due to the presence of other big companies working in the same or similar markets, like Texas Instruments, Intel, STM and others. The second reason is linked to presence in the technology park of the Polytech'Nice-Sophia and other important schools.

That will guarantee our future growth since the region will always offer both experienced design engineers and you talents to hire."

Interview with Paolo Cusinato, Design Director of MAXIM Sophia-Antipolis design center

Key Facts & Figures

 

Annual turnover: 2.3 billion euros

Companies: 245

Jobs: 9,130

Fields of activity: Biotechnologies, Biomaterials, Chemistry, Cosmetology, Biomedical Engineering, Health Image and Software, Medical Instrumentation, Pharmaceutical & Veterinary Industrie, Pharmacology, Agronomy.

 

 

 

 

Leaders:  Arkopharma, Asepta, Bayer Cropsciences, CLL Pharma, Dow Agrosciences, Galderma, IRIS Pharma, Integra Neurosciences Implants, Laboratoires Boiron, Laboratoires Genévrier, Lundbeck/Elaiapharm, MXM, NicOx, Txcell, Virbac

Success Stories: Iris Pharma, Median Technologies, Neomah, Neurelec, Nicox, Quantificare, Senseor, Virbac, Theralpha, Txcell,  VenomeTech,...

Competitive Clusters : EUROBIOMED Biocluster